Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02226562 · ClinicalTrials.gov registry record · Phase 2
Clinical Study Investigating the Efficacy of a Mouthwash in Providing Long Term Relief From Dentinal Hypersensitivity
A Phase 2 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 191
- Enrollment target
NCT02226562 is a Phase 2 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 191 participants.
The verdict
NCT02226562, a Phase 2 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 191 participants
- Enrollment target
Study Summary
The aim of this study is to investigate the longitudinal efficacy of a potassium nitrate mouthwash formulation when used as an adjunct to brushing with a standard fluoride dentifrice for the relief of dentinal hypersensitivity (DH) compared to brushing with a standard fluoride dentifrice alone. This will be a single centre, eight week, randomised, examiner blind, two treatment arm, parallel design, stratified (by maximum baseline Schiff Sensitivity Score of the two selected test teeth) study in participants with at least two sensitive teeth that meet all the criteria at the Screening and Baseline visit. Participants will be assessed at Baseline, and at four and eight weeks to monitor clinical efficacy and safety.
Interventions
- DRUG Potassium nitrate and sodium fluoride
- DRUG Standard fluoride dentifrice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2014-09-02 |
| Est. Completion | 2014-12-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02226562
The ClinicalTrials.gov registry entry for NCT02226562 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 191 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Potassium nitrate and sodium fluoride is the first listed.
NCT02226562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02226562 about?
NCT02226562 is a clinical study titled "Clinical Study Investigating the Efficacy of a Mouthwash in Providing Long Term Relief From Dentinal Hypersensitivity". The aim of this study is to investigate the longitudinal efficacy of a potassium nitrate mouthwash formulation when used as an adjunct to brushing with a standard fluoride dentifrice for the relief of dentinal hypersensitivity (DH) compared to brushing with a standard fluoride dentifrice alone. This...
What is the current status of trial NCT02226562?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 191 participants. The study started on 2014-09-02. Estimated completion is 2014-12-05.
What interventions are being tested in trial NCT02226562?
The interventions under investigation include: Potassium nitrate and sodium fluoride (DRUG), Standard fluoride dentifrice (DRUG).
Who is sponsoring clinical trial NCT02226562?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.